EUVIMEDEUVIMED entdecken
Crossref

Ferrocenyl substitution turns valproate into a glutamate decarboxylase inhibitor

Danijela N Nikolić, Marija S Genčić, Biljana Arsić, Milan S Nešić, Nikola M Stojanović, Marko Z Mladenović, Niko S Radulović

Bioorganic & Medicinal Chemistry Letters · 2026-07 · 136 · 130615

DOI: 10.1016/j.bmcl.2026.130615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026-07. Verfasst von Danijela N Nikolić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia. Hauptthemen laut MEDLINE: Glutamate Decarboxylase, Valproic Acid, Ferrous Compounds, Enzyme Inhibitors. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Republic of Serbia Ministry of Education Science and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

2-(Ferrocenylmethyl)pentanoic acid (Fc-VPA), a ferrocenyl analog of valproic acid (VPA), was synthesized, fully characterized and its effect on glutamate decarboxylase (GAD) evaluated in mouse brain homogenates using an HPLC assay. Fc-VPA produced robust, concentration-dependent GAD inhibition (IC50 = 51 ± 4 μM), comparable to 3-mercaptopropanoic acid (3-MPA; IC50 = 38 ± 2 μM), whereas VPA showed weak/biphasic effects under identical conditions. Blind docking to human GAD (PDB 2OKK) supported the trend: Fc-VPA achieved a modestly higher XSCORE than VPA (5.287 vs 4.887) and engaged a broader interaction network within the active site. These findings show that ferrocenyl substitution markedly reprograms VPA's enzyme interaction profile from weak modulation to potent inhibition. The pharmacological desirability of GAD inhibition by Fc-VPA remains to be established in cellular and in vivo models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutamate DecarboxylaseValproic AcidFerrous CompoundsEnzyme InhibitorsAnimalsMiceHumansMolecular Docking SimulationStructure-Activity RelationshipMetallocenesMolecular StructureDose-Response Relationship, DrugCatalytic Domain

Stichwörter der Autor:innen

Enzyme inhibitorFerrocene analogGABA/glutamate balanceGlutamate decarboxylase (GAD)In silico dockingValproic acid

Substanzen

Glutamate DecarboxylaseValproic AcidFerrous CompoundsEnzyme InhibitorsMetallocenesferrocene

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia.
  • Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia. Electronic address: denijum@yahoo.com.
  • Center for Mental Health Protection, University Clinical Centre Niš, Bulevar Zorana Đinđića 48, 18000 Niš, Serbia.
  • Department of Chemistry, Faculty of Sciences and Mathematics, University of Niš, Višegradska 33, 18000 Niš, Serbia. Electronic address: nikoradulovic@yahoo.com.

Förderung

  • Republic of Serbia Ministry of Education Science and Technological Development

Zitieren

APA

Nikolić, D. N., Genčić, M. S., Arsić, B., Nešić, M. S., Stojanović, N. M., Mladenović, M. Z., & Radulović, N. S. (2026). Ferrocenyl substitution turns valproate into a glutamate decarboxylase inhibitor. Bioorganic & Medicinal Chemistry Letters, 136, 130615. https://doi.org/10.1016/j.bmcl.2026.130615

Vancouver

Nikolić DN, Genčić MS, Arsić B, Nešić MS, Stojanović NM, Mladenović MZ, et al. Ferrocenyl substitution turns valproate into a glutamate decarboxylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 2026;136:130615. doi:10.1016/j.bmcl.2026.130615

BibTeX
@article{Nikoli2026,
  author = {Nikolić, Danijela N and Genčić, Marija S and Arsić, Biljana and Nešić, Milan S and Stojanović, Nikola M and Mladenović, Marko Z and Radulović, Niko S},
  title = {Ferrocenyl substitution turns valproate into a glutamate decarboxylase inhibitor},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  volume = {136},
  pages = {130615},
  doi = {10.1016/j.bmcl.2026.130615}
}
Kostenlos starten →